Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2019
Total Assets: $67.89B
Liabilities Breakdown FY2019
Total Liabilities: $36.80B
Asset Breakdown
Total Assets: $67.89B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.86B | 5.7% |
| Accounts Receivable | $5.43B | 8.0% |
| Inventory | $4.32B | 6.4% |
| Property, Plant & Equipment | $8.04B | 11.8% |
| Goodwill | $23.20B | 34.2% |
| Intangible Assets | $17.03B | 25.1% |
| Other Assets | $6.03B | 8.9% |
Liabilities Breakdown
Total Liabilities: $36.80B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.25B | 8.8% |
| Long-Term Debt | $16.66B | 45.3% |
| Other Liabilities | $16.89B | 45.9% |